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Md Hosp, Dept i f Ped, Baltimore T4 and T3 are low i n PTI compared t o healthy term i n f a n t s ( T I ) making screening r e s u l t s i n PTI d i f f i c u l t t o i n t e r p r e t . To determine the best age, the appropriate lower value o f T4, and the value o f f r e e T4(FT4) f o r screening, 76 s i c k newborns (14 TI, 62 PTI) had s e r i a l T4, T3, TSH, and FT4 measured u n t i l discharge. TSH values were normal (NL) i n a l l b u t one TI. Cumulative r e s u l t s showed T4, T3, and FT4 a l l s i g n i f i c a n t l y lower i n PTI than s i c k TI. T3 values gradually rose i n PTI over 5 weeks. None o f the weekly FT4 values were s i g n i f i c a n t l y d i f f e r e n t : Week 1 2 3 4 b 5 cumulative* T I ng/ml 2.00 2.00 1.55 2.12 1.86 1.93 SD (N) . 61(8) . 44(10) Female PTI were s i g n i f i c a n t l y higher than male PTI f o r cumul a t i v e values o f T4, T3, FT4. The best lower 1 i m i t f o r T4 was 45 ng/ml a t a l l ages. This i s the mean-1.65 SD (lower 5%) i n T I a t 1 t o 3 wks, and the Maryland s t a t e l a b a f t e r 3 wks. This value yielded 4/30, 2/27, 3/25, 3/21, and 0/19 abNL tests a t wks 1 t o 5 , respectively. T3 and FT4 were n o t as s p e c i f i c . Of 11 PTI withabNL T4, only 2 died before values returned t o NL. We conclude t h a t screening (using 45 ng/ml T4) i s possible a t any age. Should consecutive T4's be abNL, T3 o r FT4 may exclude hypothyroidism.
Alberto Ha ek and Glenn T.
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Twelve dwarfed children (3-13 yrs. of age) with heights < 4
SDs below t h e mean, growth r a t e < 4 cmlyr. and retarded bone ages were investigated. They a l l had low Somatomedin-C (Sm-C < -25
Ulml) b a s a l l e v e l s and standard G H provocative s t i m u l i . Following a 10 day course of GH treatment a t a dose of ,168 u / k g 3 I b , they were seen a t 12 weeks f o r height measurements. Based on t h e endogenous GH l e v e l s , and the plasma Sm-C and growth increments, 3 s e p a r a t e groups could be i d e n t i f i e d . Predicted growth r a t e was calculated according t o Rudman's protocol (JCEM 48,472, 1979 .56 i . i n 6-in Group 1 r e p r e s e n t s children with c l a s s i c a l growth hormone def i c i e n t dwarfism a l l of whom responded t o treatment with a r i s e i n Sm-C and enhanced growth. Group 2 i s a s e t of twins with Laron type dwarfism. Group 3 probably represents children with b i o l o g i c a l l y i n a c t i v e but immunoreactive GH.
I n conclusion, t h e a c u t e increase i n Sm-C l e v e l s appears t o predict b e s t an adequate growth response t o exogenous GH.
SERUM SOMATOMEDIN-C CONCENTRATIONS (SMC) I N PRETERM INFANTS. Laura S. Hillman and Sandra L. Blethen, Sch., S t . Louis Children's Hosp., Dept. of p e d i a t r i c s , S t . Louis, MO.
An animal model suggests t h a t vitamin D deficiency causes l i n e a r growth r e t a r d a t i o n by decreasing SMC. To d e f i n e normal SMC i n preterm i n f a n t s where low 25-hydroxyvitamin D l e v e l s (25-OHD) a r e associated with l a t e r growth r e t a r d a t i o n , SMC were measured by RIA i n s e r i a l samples from 37 i n f a n t s of g e s t a t i o n 30.qt1.9wks and birthweight 1183+182gms. 1 3 were on standard formula plus 4001.U. vitamin D ( c o n t r o l ) ; 12, a high calcium, high phosphorus formula (Ca-P); and 12, standard formula plus luglkg 25-hydroxyc h o l e c a l c i f e r o l (25-HCC).
SMC remained low over t h e f i r s t 9wks of l i f e but had increased (p<.005 by paired t -t e s t ) a t 12wks. Although t h e r e were no s i g n i f i c a n t d i f f e r e n c e s among t h e 3 groups, t h e 25-HCC t r e a t e d group had t h e lowest SMC and highest 25-OHD. SMC did not c o r r e l a t e with serum 25-OHD, g e s t a t i o n a l age, length, weight, o r weight gain a t any age. The delayed increase i n SMC may be developmental s i n c e s e v e r a l other liver-made p r o t e i n s (DBP, ceruloplasmin, albumin) follow a s i m i l a r time course. I n human prematures, SMC i s not decreased by low but not r a c h e t i c 25-OHD. I n addition, t h e r e is unsaturated SMBP found mainly i n t h e 35-40K region. W e have compared l e v e l s of unsaturated SMBP i n 7 normal a d u l t s t o 21 children with growth hormone deficiency before and during treatment with hGH 0.1UI~gIday x 4 days. The SM-C/IGF-I content of each plasma was measured by R I A . There was a s i g n i f icant (~0 . 0 1 ) difference i n unsaturated SMBP between normal cont r o l s ( 1 7 . 8 3 . 8 %Bound/20ul) and untreated hypopituitary p a t i e n t s (27.822.2 %Bound/20ul). Thus a lower SM-C/IGF-I was associated with a higher unsaturated SMBP. Furthermore, t h e r e was a signif i c a n t negative c o r r e l a t i o n between SM-C/IGF-1 content and unsaturated SMBP i n t h e untreated hypopituitary p a t i e n t s (r-0.73, p 0 . 0 0 1 ) .
Treatment with hGH normalized t h e mean unsaturated SMBP i n t h e hypopituitary p a t i e n t s within two days. F u l l d i splacement curves and Scatchard a n a l y s i s showed t h a t t h e increased unsaturated SMBP i n hypopituitary p l sma was e n t i r e l y due t o an increased a f f i n i t y ( 8 . 4 5 . 9 x 10-I' M) when compared t o normal ( 2 . 3 5 . 2 x 1 0 -9~) . W e conclude t h a t a higher a f f i n i t y form of unsaturated SMBP i s uniquely present i n hypopituitarism which disappears with G H treatment. This change is i n c o n t r a s t t o t h e low l e v e l s of acid s t a b l e SMBP which increase a f t e r GH. Hosp. Sick Child., Depts. Peds. & Radiol., Toronto. Extension of t h e subarachnoid space through a d e f e c t i v e diaphragma s e l l a may cause progressive enlargement of t h e p i t u i t a r y fossa, and may r e s u l t i n secondary endocrine disturbances, CSF rhinorrhea or v i s u a l f i e l d defects. Symptoms usually present i n t h e f o u r t h o r f i f t h decade, and r e p o r t s i n children a r e very rare.
A 13.4 year old male presented following minor trauma t o t h e face, when symmetrical p i t u i t a r y f o s s a enlargement was noted on s k u l l x-ray.
The s e l l a volume was 3.2 times normal mean volume f o r age and t h e r e was some minimal c a l c i f i c a t i o n within t h e diaphragm. He was t o t a l l y asymptomatic, and on physical examination h i s height, weight and sexual development were appropriate f o r age, h i s v i s u a l f i e l d s were i n t a c t and t h e r e were no f o c a l CNS signs or thyroid enlargement. Endocrine evaluation showed normal b a s a l plasma l e v e l s of T4 (7.7 pgmldl), TSH (2.2 W/ml), LH and FSH (2 and 5 mIUIml) and p r o l a c t i n (6.9 nglml). I n response t o i n t r avenous i n s u l i n and thyrotropin r e l e a s i n g hormone, t h e r e were s a ti s f a c t o r y increases i n G H (A 12 nglml), c o r t i s o l (A 13.5 ugmldl), TSH (A 10.6 uU/ml) and p r o l a c t i n (A 11.1 ng/ml), and h i s respons e s t o gonadotropin r e l e a s i n g hormone were appropriate f o r h i s degree of sexual development (A LH 26 mIU/ml; A FSH 2 mIU/ml). A CT scan performed a f t e r i n j e c t i o n of matrizamide c o n t r a s t i n t o t h e lumbar subarachnoid space, confirmed t h a t the s e l l a was "empty", with a narrow rim of p i t u i t a r y t i s s u e visualized against t h e a n t e r i o r wall. No p i t u i t a r y hormones were detected i n t h e CSF. Empty s e l l a syndrome i n some p a t i e n t s , may t h e r e f o r e possi b l y have i t s o r i g i n s i n childhood.
*nl a d u l t .4-2.0ulm1, term cord 0.55+.22u/ml, ab provided by NPA. Peripheral r e s i s t a n c e t o thyroid hormone i s a r a r e syndrome characterized by elevated serum t o t a l and f r e e T4 and Tg concent r a t i o n s , an absence of c l i n i c a l manifestations of hyperthyroidism and abnormal TSH suppression. W e studied a c l i n i c a l l y euthyroid 6 month old i n f a n t , the youngest p a t i e n t with t h i s syndrome y e t described, t o determine the mechanism of thyroid hormone r e s i stance. The degree of p i t u i t a r y i n s e n s i t i v i t y t o Tg was i n v e s t igated by measuring serum T4 and TSH, and the TSH response t o TRH infusion (100 pg) i n response t o increasing doses of T?. .4 1.6 3.2 Four times t h e replacement dose of T3 (40 pglday) was required t o normalize the serum T4 and the response t o TRH. With 80 pglday T j the TSH response t o TRH was v i r t u a l l y abolished, a s occurs i n hyperthyroidism, but there were no c l i n i c a l signs of thyroid hormone excess. Specific nuclear Tg binding was compared i n cultured skin f i b r o b l a s t s from the p a t i e n t and a normal i n f a n t . Binding was n6rmal a t low concentrations of unlabelled T j , but a t high concentrations there was evidence f o r a second low-affinity T j receptor. While r e s i s t a n c e t o thyroid hormone has been demons t r a t e d i n t h i s i n f a n t , the c e l l u l a r mechanisms a r e unclear. 
